跳至主要内容
临床试验/NCT05057455
NCT05057455已完成不适用

Effectiveness of the Cytokine Hemadsorption on the Clinical Progression and Mortality of Intensive Care Patients With Sepsis

Biruni University1 个研究点 分布在 1 个国家目标入组 39 人开始时间: 2020年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
39
试验地点
1
主要终点
IL-6

研究概览

简要总结

In this prospective study, we aimed to compare the laboratory and clinical results of cytokine hemadsorption as an immunomodulation therapy in ICU patients diagnosed with sepsis or septic shock.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 100 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • the patients were the available data of clinical and laboratory diagnosis of sepsis and septic shock
  • detection of gram-negative bacterial agent in blood or sputum culture.
  • patients who had the shock symptoms such as hypotension, tachycardia or fever during the course of sepsis.

排除标准

  • had uncontrolled hemorrhage,
  • diagnosed with cardiac failure at stage 4 or renal failure at stage 4 or hepatic liver failure at stage 4
  • cancer at the end stage or admitted with acute coronary syndrome.

结局指标

主要结局

IL-6

时间窗: 1 YEARS

levels of IL-6

次要结局

未报告次要终点

研究者

发起方
Biruni University
申办方类型
Other
责任方
Principal Investigator
主要研究者

IKUPELI

investigator

Biruni University

研究点 (1)

Loading locations...

相似试验